Stay updated with breaking news from Grant Pickering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 2,616 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $72.06, for a total transaction of $188,508.96. Following the transaction, the chief executive officer now owns 144,746 shares in the company, valued […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 15,000 shares of the company’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $69.43, for a total transaction of $1,041,450.00. Following the completion of the sale, the chief executive officer now directly owns 477,847 shares […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 15,000 shares of Vaxcyte stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $61.92, for a total value of $928,800.00. Following the completion of the sale, the chief executive officer now directly owns 477,847 shares of […]
-- Topline Safety, Tolerability and Immunogenicity Data from VAX-31 Phase 1/2 Study (n=1,015) Expected in Third Quarter of 2024 -- -- VAX-31 is Designed...
SAN CARLOS, Calif., Nov. 28, 2023 -- Vaxcyte, Inc. , a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today...